DIRS.INFO The most relevant business & tech news

Periods of high inflation would offset those when inflation was low as occurred between the financial crisis and the pandemic. Those concerns may not matter anymore if the pandemic has driven inflation and interest rates chronically higher. Speaking at a Boston Fed labor market conference in November, Kohn said the new framework showed the risks of not keeping inflation at bay to begin with. "Probing" for maximum employment "can't ignore...inflation risks," Kohn said, calling for a return to a strategy disavowed in the last review. "I think preemptive tightening is best-practice central banking, and I hope they return to allowing that."

Persons: Joshua Roberts, Jerome Powell, There's, Miesha Williams, Powell, Charles Evans, Evans, Fed, Loretta Mester, Austan Goolsbee, Goolsbee, Donald Kohn, Kohn, Howard Schneider, Dan Burns, Andrea Ricci Organizations: Federal Reserve, REUTERS, Rights, U.S, Federal, Spelman College, Reuters, Chicago Fed, Chicago, Cleveland Fed, Boston Fed, Thomson Locations: Washington , U.S, Atlanta

☆ The door is still open for more rate hikes, says former Fed official Donald Kohn
▼ + stars: | 2023-11-02 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe door is still open for more rate hikes, says former Fed official Donald KohnDonald Kohn, former Fed vice chairman, joins 'Squawk on the Street' to discuss if Kohn thinks the Federal Reserve is done with rate hikes, where investors are on the 10-year yield, and more.

Persons: Donald Kohn Donald Kohn, Kohn

The U.S. economy has avoided a threatened banking crisis and financial markets have not only aligned with the Federal Reserve's tight-credit policies but of late even helped the process by bidding up market interest rates. "I think Powell’s main effort is going to be explaining to what degree you want to hold (interest rates) higher for longer in the current outlook." Investors in contracts tied to the Fed's benchmark interest rate currently expect the Fed to begin reducing the policy rate next year from the current level set between 5.25% and 5.5%. Fed officials in fact have begun discussing the possibility of rate cuts down the road, at least in the context of steadily falling inflation. If inflation does decline as expected, Fed officials including Powell have suggested rate reductions might be appropriate to maintain a roughly constant inflation-adjusted "real rate."

Persons: Jerome Powell, Jackson, Jim Urquhart, JACKSON, Antulio Bomfim, Powell, who've, isn't, Adam Posen, William English, Donald Kohn, Howard Schneider, Andrea Ricci Organizations: REUTERS, Federal, Kansas, Fed, Northern Trust, Bank of England's, Committee, Peterson Institute for International Economics, Yale School of Management, Brookings Institution, Thomson Locations: Teton, Jackson , Wyoming, U.S, , Wyoming, Washington

☆ Economists are torn on whether the Fed’s pause will backfire
▼ + stars: | 2023-06-14 | by ( Elisabeth Buchwald | ) edition.cnn.com time to read: +3 min

Fed Chair Jerome Powell said the rate hike pause will give officials more time to evaluate the effects rate hikes have had on the economy so far. But he left the door open for the possibility of more rate hikes at future meetings. “Every time they relaxed rates inflation would ratchet up,” said Michael Bordo, an economics professor and director of the Center for Monetary and Financial History at Rutgers University. Many economists agree the Fed is not confronting the extreme dilemma Paul Volcker faced during his time as Fed Chair from 1979 to 1987. The Fed’s pause “doesn’t necessarily have adverse implications for inflation,” he said.

Persons: Jerome Powell, ” Powell, ”, Michael Bordo, Paul Volcker, “, Donald Kohn, Powell, Bordo, George Selgin Organizations: New, New York CNN, Federal, Center for Monetary, Rutgers University, Fed, CNN, Cato Institute Locations: New York

☆ Fed made right call on interest rate decision, says former Fed official Donald Kohn
▼ + stars: | 2023-05-04 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFed made right call on interest rate decision, says former Fed official Donald KohnDonald Kohn, former Fed vice chairman and current senior fellow at Brookings, joins 'Squawk on the Street' to discuss the Fed's decision to raise rates another 25 bps, and the Fed's regulatory focus.

☆ A drug company abandoned a treatment for ‘bubble boy disease.’ After a 5-year fight, this little girl is about to get it
▼ + stars: | 2023-04-27 | by ( Elizabeth Cohen Lauren Mascarenhas | Elizabeth Cohen | Lauren Mascarenhas | ) edition.cnn.com time to read: +29 min

The Sulacks weighed their options: Have a transplant with a match that was less than ideal – far less – or wait for gene therapy to become available. The news release didn’t say anything else about the SCID gene therapy. Or was the company abandoning its plans for SCID gene therapy altogether? In February, 2021, the parents of more than 20 children who were waiting for the gene therapy treatment, including the Sulacks, wrote a letter to Gaspar. Insurance companies have sometimes balked at paying for gene therapy, which is typically given in one treatment.

☆ Kids with 'bubble boy' disease could finally get access to a life-saving gene therapy, as a study starts back up at UCLA
▼ + stars: | 2022-12-27 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +4 min

UCLA researchers are restarting a study to give a gene therapy to kids with an ultra-rare disease. Without gene therapy, doctors treat kids with SCID using enzyme-replacement therapies, if they are ineligible for bone-marrow transplants. In an email to Insider, Kohn said he expects to be able to treat between three and six patients with his current funding. Drug companies have shown little interest in the treatments because the complexity of the treatments and tiny number of eligible patients limit potential profits. Drug companies have deprioritized or shelved gene-therapy programs to treat a range of rare diseases, including Wiskott-Aldrich syndrome, MPS, Batten disease, chronic granulomatous disease, Rett syndrome, and Fabry disease.

☆ Fed on track for tens of billions in losses amid inflation fight
▼ + stars: | 2022-10-28 | by ( Michael S. Derby | ) www.reuters.com time to read: +5 min

Those losses will not impede the central bank’s ability to conduct monetary policy but could over time expose it to friction on the political front. What’s more, getting a handle on how much money the Fed might lose is difficult given the highly unsettled economic outlook. FED PAYS TO PARK CASH ON SIDELINESThe Fed is losing money due to the mechanics of monetary policy. By paying interest to a mix of banks, money funds and others, the Fed keeps the federal funds rate in its desired range. The Fed funds its operations through services it provides banks and via interest from bonds it owns.

Search resuls for: "Donald Kohn"

8 mentions found